CoChat
Sign Up
Cited by 395Healthcare cost, quality, practicesClinical Reasoning and Diagnostic SkillsClinical Laboratory Practices and Quality Control

The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index.

Principles for high-quality, high-value testing

Open access
Power, Michael, Fell, Greg, Wright, Michael·2013·Evidence Based Medicine
DOI 10.1136/eb-2012-100645PMC PMC3585491
Open this paper in CoChat — free accountOpen PDF

Abstract

A survey of doctors working in two large NHS hospitals identified over 120 laboratory tests, imaging investigations and investigational procedures that they considered not to be overused. A common suggestion in this survey was that more training was required. And, this prompted the development of a list of core principles for high-quality, high-value testing. The list can be used as a framework for training and as a reference source. The core principles are: (1) Base testing practices on the best available evidence. (2) Apply the evidence on test performance with careful judgement. (3) Test efficiently. (4) Consider the value (and affordability) of a test before requesting it. (5) Be aware of the downsides and drivers of overdiagnosis. (6) Confront uncertainties. (7) Be patient-centred in your approach. (8) Consider ethical issues. (9) Be aware of normal cognitive limitations and biases when testing. (10) Follow the ‘knowledge journey’ when teaching and learning these core principles.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/eb-2012-100645

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Reclassification possibilities with the last in a series of tests. This figure is only reproduced in colour in the online version.
Figure 1 Reclassification possibilities with the last in a series of tests. This figure is only reproduced in colour in the online version.CC BY-NC · PubMed Central
Figure 2 Receiver operating characteristic (ROC) curves for C reactive protein (CRP) and procalcitonin (PCT) levels for serious infection. The area between the ROC curves represents the net reclassification index (NRI), which is negative for PCT compared to CRP. The graph is from van den Bruel et al,2 and reproduced with permission from the publishers. This figure is only reproduced in colour in the online version.
Figure 2 Receiver operating characteristic (ROC) curves for C reactive protein (CRP) and procalcitonin (PCT) levels for serious infection. The area between the ROC curves represents the net reclassification index (NRI), which is negative for PCT compared to CRP. The graph is from van den Bruel et al,2 and reproduced with permission from the publishers. This figure is only reproduced in colour in the online version.CC BY-NC · PubMed Central
Figure 3 Rules of thumb for testing when sensitivity and specificity are 80–90%, and positive and negative likelihood ratios 4–9 and 0.3–0.1.5 The horizontal line shows the threshold for action. Upward-sloping lines point to positive predictive values. Downward-sloping lines point to negative predictive values. The angles of the prediction lines reflect the likelihood ratios. Thick prediction lines show results that change management. Thin prediction lines show results that will not change management. The moderate slopes of the prediction lines reflect the combination of moderately high sensitivity and moderately high specificity. Prevalence categories are labelled ‘Don't test’ if the result of testing will not change management. This figure is only reproduced in colour in the online version.
Figure 3 Rules of thumb for testing when sensitivity and specificity are 80–90%, and positive and negative likelihood ratios 4–9 and 0.3–0.1.5 The horizontal line shows the threshold for action. Upward-sloping lines point to positive predictive values. Downward-sloping lines point to negative predictive values. The angles of the prediction lines reflect the likelihood ratios. Thick prediction lines show results that change management. Thin prediction lines show results that will not change management. The moderate slopes of the prediction lines reflect the combination of moderately high sensitivity and moderately high specificity. Prevalence categories are labelled ‘Don't test’ if the result of testing will not change management. This figure is only reproduced in colour in the online version.CC BY-NC · PubMed Central
Figure 4 SpIn—rule of thumb for using a test with high specificity and low sensitivity. For example, HbA1c≥6.5% for diagnosing diabetes has 99% specificity and 30% sensitivity, and positive and negative likelihood ratios 30 and 0.7.6 The horizontal line shows the threshold for action. Upward-sloping lines point to positive predictive values. Downward-sloping lines point to negative predictive values. The angles of the prediction lines reflect the likelihood ratios. Thick prediction lines show results that change management. Thin prediction lines show results that will not change management. The gentle downward and steep upward slopes of the prediction lines reflect the combination of low sensitivity and high specificity. This figure is only reproduced in colour in the online version.
Figure 4 SpIn—rule of thumb for using a test with high specificity and low sensitivity. For example, HbA1c≥6.5% for diagnosing diabetes has 99% specificity and 30% sensitivity, and positive and negative likelihood ratios 30 and 0.7.6 The horizontal line shows the threshold for action. Upward-sloping lines point to positive predictive values. Downward-sloping lines point to negative predictive values. The angles of the prediction lines reflect the likelihood ratios. Thick prediction lines show results that change management. Thin prediction lines show results that will not change management. The gentle downward and steep upward slopes of the prediction lines reflect the combination of low sensitivity and high specificity. This figure is only reproduced in colour in the online version.CC BY-NC · PubMed Central
Figure 5 SnOut—rule of thumb for using a test with high sensitivity and low specificity. For example genetic typing for coeliac disease has 99% sensitivity and 54% specificity, and positive and negative likelihood ratios 2.2 and 0.02.7 The horizontal line shows the threshold for action. Upward-sloping lines point to positive predictive values. Downward-sloping lines point to negative predictive values. The angles of the prediction lines reflect the likelihood ratios. Thick prediction lines show results that change management. Thin prediction lines show results that will not change management. The steep downward and gentle upward slopes of the prediction lines reflect the combination of high sensitivity and low specificity. This figure is only reproduced in colour in the online version.
Figure 5 SnOut—rule of thumb for using a test with high sensitivity and low specificity. For example genetic typing for coeliac disease has 99% sensitivity and 54% specificity, and positive and negative likelihood ratios 2.2 and 0.02.7 The horizontal line shows the threshold for action. Upward-sloping lines point to positive predictive values. Downward-sloping lines point to negative predictive values. The angles of the prediction lines reflect the likelihood ratios. Thick prediction lines show results that change management. Thin prediction lines show results that will not change management. The steep downward and gentle upward slopes of the prediction lines reflect the combination of high sensitivity and low specificity. This figure is only reproduced in colour in the online version.CC BY-NC · PubMed Central
Figure 6 The blue line shows how the post-test probability of HIV rises as more diagnostic information becomes available from the history, examination and laboratory tests. In contrast to figures 2–4, the vertical scale is logarithmic in order to expand the scope of the extremes of the axis. With log scaling, the graph can show how the final test (HIV western blot) limits the false-positive rate to less than around 1 in 10 000—anything less than this is unacceptable for diagnosing HIV. The Figure is adapted from Henríquez.8 Probabilities in the labels are qualitatively, but not quantitatively, accurate. This figure is only reproduced in colour in the online version.
Figure 6 The blue line shows how the post-test probability of HIV rises as more diagnostic information becomes available from the history, examination and laboratory tests. In contrast to figures 2–4, the vertical scale is logarithmic in order to expand the scope of the extremes of the axis. With log scaling, the graph can show how the final test (HIV western blot) limits the false-positive rate to less than around 1 in 10 000—anything less than this is unacceptable for diagnosing HIV. The Figure is adapted from Henríquez.8 Probabilities in the labels are qualitatively, but not quantitatively, accurate. This figure is only reproduced in colour in the online version.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

Sorted by citations

See all 395

Related

Metadata

Authors
Power, M., Fell, G., & Wright, M.
Affiliations
  • Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
  • Airedale NHS Foundation Trust (GB)
Corresponding author
Power, Michael
ORCID
Venue
Evidence Based Medicine
Publisher
BMJ
Published
2012-06-27
Volume
18
Issue
1
Pages
5-10
ISSN
  • 1356-5524 (ISSN-L)
  • 1473-6810
DOI
10.1136/eb-2012-100645
PMC
PMC3585491
OpenAlex
W2051681038
Cited by
394
References
24
Citations by year
2026: 40 · 2025: 84 · 2024: 82 · 2023: 83 · 2022: 58 · 2021: 33 · 2020: 4 · 2019: 2 · 2018: 4 · 2014: 2 · 2013: 2
FWCI
2.27
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • BMJ Evidence-Based Medicine (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Health Professions › General Health Professions › Healthcare cost, quality, practices
  • Health Sciences › Medicine › Family Practice › Clinical Reasoning and Diagnostic Skills
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
Keywords
overuse of diagnostic testing, high-value care, evidence-based practice, test performance, overdiagnosis, patient-centered care, cognitive biases, medical training, NHS doctors, diagnostic imaging
MeSH terms
Cost-Benefit Analysis, Diagnostic Tests, Routine, Humans, Predictive Value of Tests, Quality of Health Care, Sensitivity and Specificity, Evidence-Based Medicine, Uncertainty

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review